stock
Entered 2024.03.27 07:53 Modified 2024.03.27 07:53
The mother and daughter friendly share ratio is 42.66%… Just ahead of its siblings
The court also decided to dismiss the brothers’ request for a preliminary injunction.
In the dispute over the management rights of Hanmi Pharmaceutical Group, the founder’s eldest wife and daughter won with the support of the court and the National Pension Service. The hope of the rest of the eldest sons and the second son, who oppose the integration with OCI promoted by the mother and daughter, is to win the support of minority shareholders. This is because the difference in shareholding between the two sides is not large.
According to the related industry on the 27th, the Fiduciary Responsibility Expert Committee of the National Pension Service agreed to the agenda for Hanmi Science’s regular general shareholders meeting to appoint six director candidates recommended by Hanmi Pharmaceutical Group Chairman Song Young-sook and Hanmi Pharmaceutical President Lim Joo-hyun, and the five proposed by the brothers The night before, I expressed my opposition to the plan to appoint directors. At Hanmi Science’s regular general shareholders’ meeting held the next day, the mother-daughter side (henceforth, a 35% stake) and brothers Lim Jong-yoon and Jong-hoon (28.42%) will compete for votes for appoint directors. Previously, the brothers’ side appeared to be winning by gaining the support of Hanyang Precision Chairman Shin Dong-guk (12.15%), the single largest shareholder, but the tide turned when the National Pension Service (7.66%) sided with the mother and Hanmi Science shares currently secured by both parties The friendly share ratio is 42.66% for the mother and daughter, and 40.57% for the brothers, including Chairman Shin’s share. The difference is not big yet.
Now, the only thing the brothers can rely on is minority shareholders (16.77%). This is because the request for a preliminary injunction to prohibit the issuance of new shares of Hanmi Science to prevent the integration of Hanmi Pharmaceutical Group and OCI was dismissed the day before. Part 31 of the Suwon District Court civil agreement said, “Although it is suspected that Chairman Song and others have the purpose of strengthening management or control rights, they have reviewed it over a long period of time, including searching for an investment company, over a period of two years, and considering this process, the opinion of the management of the board of directors should be respected, and he explained the reason for the decision to reject the request for a temporary injunction, saying, “It appears that it will be done. “
Reporter Han Kyung-woo, Hankyung.com case@hankyung.com
#Mother #daughter #Hanmi #Pharmaceutical #court #national #pension #business.. #brothers #rely #minority #shareholders
